ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.80
0.04 (1.45%)
At close: Jun 26, 2025, 3:59 PM
2.77
-1.07%
After-hours: Jun 26, 2025, 07:54 PM EDT
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending March 31, 2025, ImmunityBio generated $16.52M in revenue.
Revenue (ttm)
$14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
$21.97K
Employees
671
Market Cap
2.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|